COMPASS Pathways 過去の業績
過去 基準チェック /06
COMPASS Pathwaysの収益は年平均-28.9%で減少しているが、Biotechs業界はgrowingで19%年平均の収益となった。
主要情報
-28.9%
収益成長率
11.5%
EPS成長率
| Biotechs 業界の成長 | 17.0% |
| 収益成長率 | n/a |
| 株主資本利益率 | -74.8% |
| ネット・マージン | n/a |
| 前回の決算情報 | 30 Sep 2024 |
最近の業績更新
Recent updates
Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity
Nov 01Compass Pathways: Sector-Wide Reality Check Needed Post FDA Lykos MDMA Decision
Aug 19Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies
Jul 08Psychedelics Closer To Commercialization; Compass Far And Away The Leader
May 23COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut?
Apr 25Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play
Feb 08Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth
Dec 06
Booker again pushes for easier access to psychedelics for terminally ill patients
Oct 19Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation
Aug 13COMPASS Pathways And The Trillion Dollar Opportunity
Aug 11COMPASS Pathways ADS Q2 2022 Earnings Preview
Aug 03COMPASS Pathways names new CEO
Jul 19Compass Pathways: Shares Look Cheap But Proving Psilocybin Case Won't Be Easy
Jun 30We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely
Apr 28Checking In On Compass Pathways
Mar 02We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth
Dec 29Compass Pathways: Psychedelics For Mental Health
Nov 23Compass Faces Tricky Road To Approval For Its Psychedelic Depressive Therapy
Sep 17COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans
Sep 15Compass Pathways: Huge Growth Potential, But I'm Cautious
Jun 04COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans
May 25COMPASS Pathways raises $144M capital via equity offering
Apr 30COMPASS Pathways launches public offering
Apr 27We're Not Very Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Rate
Feb 08Psilocybin Will Change Mental Health, Compass Pathways Could Be At The Forefront
Jan 01Compass Pathways: Risky And Overvalued
Dec 18What Type Of Shareholders Make Up COMPASS Pathways plc's (NASDAQ:CMPS) Share Registry?
Dec 18収支内訳
収支内訳
COMPASS Pathways の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Sep 24 | 0 | -144 | 54 | 100 |
| 30 Jun 24 | 0 | -139 | 52 | 90 |
| 31 Mar 24 | 0 | -129 | 50 | 82 |
| 31 Dec 23 | 0 | -118 | 49 | 75 |
| 30 Sep 23 | 0 | -117 | 51 | 66 |
| 30 Jun 23 | 0 | -102 | 50 | 58 |
| 31 Mar 23 | 0 | -95 | 48 | 53 |
| 31 Dec 22 | 0 | -92 | 45 | 51 |
| 30 Sep 22 | 0 | -86 | 48 | 46 |
| 30 Jun 22 | 0 | -84 | 46 | 45 |
| 31 Mar 22 | 0 | -80 | 43 | 41 |
| 31 Dec 21 | 0 | -72 | 39 | 34 |
| 30 Sep 21 | 0 | -65 | 31 | 27 |
| 30 Jun 21 | 0 | -66 | 28 | 23 |
| 31 Mar 21 | 0 | -64 | 31 | 20 |
| 31 Dec 20 | 0 | -60 | 28 | 19 |
| 30 Sep 20 | 0 | -49 | 24 | 19 |
| 30 Jun 20 | 0 | -38 | 20 | 16 |
| 31 Mar 20 | 0 | -25 | 11 | 13 |
| 31 Dec 19 | 0 | -20 | 9 | 10 |
質の高い収益: CMPSは現在利益が出ていません。
利益率の向上: CMPSは現在利益が出ていません。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: CMPSは利益が出ておらず、過去 5 年間で損失は年間28.9%の割合で増加しています。
成長の加速: CMPSの過去 1 年間の収益成長を 5 年間の平均と比較することはできません。現在は利益が出ていないためです。
収益対業界: CMPSは利益が出ていないため、過去 1 年間の収益成長をBiotechs業界 ( 13.6% ) と比較することは困難です。
株主資本利益率
高いROE: CMPSは現在利益が出ていないため、自己資本利益率 ( -74.77% ) はマイナスです。